E0767 Insurance Policy Changes

HCPCS E0767 is officially defined as "Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories." HCPCS E0767 is referenced in 3 tracked payer policy changes from Aetna, CareSource, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS E0767 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.